Predictive Value of ST Resolution Analysis Performed Immediately Versus at Ninety Minutes After Primary Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 105, Issue 4, 2010, Pages 467-474

  Kumar, Saurabh ^a   Sivagangabalan, Gopal ^a   Hsieh, Calvin ^a   Ryding, Alisdair D S ^b   Narayan, Arun ^a   Chan, Hera ^a   Burgess, David C ^a   Ong, Andrew T L ^a   Sadick, Norman ^a   Kovoor, Pramesh ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; BLOOD CLOT LYSIS; CORONARY ARTERY BLOOD FLOW; DEATH; EPICARDIUM; FEMALE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROVASCULARIZATION; MORTALITY; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PERFUSION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; ST SEGMENT; ST SEGMENT RESOLUTION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; CONFIDENCE INTERVALS; CORONARY THROMBOSIS; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STENTS; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TIME FACTORS; VASODILATOR AGENTS;

EID: 75349108976     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.10.017     Document Type: Article

References (30)

1. De Lemos J.A., and Braunwald E. ST segment Resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol 38 (2001) 1283-1294
2. Roe M.T., Ohman E.M., Maas A.C., Christenson R.H., Mahaffey K.W., Granger C.B., Harrington R.A., Califf R.M., and Krucoff M.W. Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. J Am Coll Cardiol 37 (2001) 9-18
3. Van't Hof A.W.J., Liem A., Suryapranata H., Hoorntje J.C., de Boer M.J., and Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 97 (1998) 2302-2306
4. Poli A., Fetiveau R., Vandoni P., del Rosso G., D'Urbano M., Seveso G., Cafiero F., and De Servi S. Integrated analysis of myocardial blush and ST-segment elevation recovery after successful primary angioplasty: real-time grading microvascular reperfusion and prediction of early and late recovery of left ventricular function. Circulation 106 (2002) 313-318
5. Sorajja P., Gersh B.J., Costantini C., McLaughlin M.G., Zimetbaum P., Cox D.A., Garcia E., Tcheng J.E., Mehran R., Lansky A.J., Kandzari D.E., Grines C.L., and Stone G.W. Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction. Eur Heart J 26 (2005) 667-674
6. Schroder R., Wegscheider K., Schroder K., Dissmann R., and Meyer-Sabellek W. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens: a substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. J Am Coll Cardiol 26 (1995) 1657-1664
7. Schröder K., Wegscheider K., Zeymer U., Tebbe U., and Schröder R. Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction. Lancet 358 (2001) 1479-1486
8. Buller C.E., Fu Y., Mahaffey K.W., Todaro T.G., Adams P., Westerhout C.M., White H.D., van't Hof A.W., Van de Werf F.J., Wagner G.S., Granger C.B., and Armstrong P.W. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation 118 (2008) 1335-1346
9. Brodie B.R., Stuckey T.D., Hansen C., VerSteeg D.S., Muncy D.B., Moore S., Gupta N., and Downey W.E. Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 95 (2005) 343-348
10. Prasad A., Stone G.W., Aymong E., Zimetbaum P.J., McLaughlin M., Mehran R., Garcia E., Tcheng J.E., Cox D.A., Grines C.L., Gersh B.J., and CADILLAC trial. Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial. Am Heart J 147 (2004) 669-675
11. Sciagrà R., Parodi G., Migliorini A., Valenti R., Antoniucci D., Sotgia B., and Pupi A. ST-segment analysis to predict infarct size and functional outcome in acute myocardial infarction treated with primary coronary intervention and adjunctive abciximab therapy. Am J Cardiol 97 (2006) 48-54
12. De Luca G., Suryapranata H., Ottervanger J.P., Hoorntje J.C., Gosselink A.T., Dambrink J.H., de Boer M.J., and van't Hof A.W. Postprocedural single-lead ST-segment deviation and long-term mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Heart 94 (2008) 44-47
13. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., Hand M., Hochman J.S., Krumholz H.M., Kushner F.G., Lamas G.A., Mullany C.J., Pearle D.L., Sloan M.A., Smith S.C., Alpert J.S., Anderson J.L., Faxon D.P., Fuster V., Gibbons R.J., Gregoratos G., Halperin J.L., Hiratzka L.F., Hunt S.A., Jacobs A.K., and Ornato J.P. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 1999 guidelines of the management of patients with acute myocardial infarction). Circulation 110 (2004) 588-636
14. Schröder R. Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. Circulation 110 (2004) e506-e510
15. Terkelsen C.J., and Andersen H.R. Value of ST resolution analysis in the era of primary percutaneous coronary intervention. Heart 94 (2008) 13-15
16. Schröder R., Zeymer U., Wegscheider K., and Neuhaus K.L. Comparison of the predictive value of ST segment elevation resolution at 90 and 180 min after start of streptokinase in acute myocardial infarction: a substudy of the hirudin for improvement of thrombolysis (HIT)-4 study. Eur Heart J 20 (1999) 1563-1571
17. de Lemos J.A., Antman E.M., Giugliano R.P., Morrow D.A., McCabe C.H., Cutler S.S., Charlesworth A., Schröder R., Braunwald E., and In TIME-II Investigators. Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. Intravenous nPA for Treatment of Infarcting Myocardium Early-II. Am J Cardiol 86 (2000) 1235-1237 A5
18. Grines C.L., Browne K.F., Marco J., Rothbaum D., Stone G.W., O'Keefe J., Overlie P., Donohue B., Chelliah N., Timmis G.C., Vlietstra R.E., Strzelecki M., Puchrowicz-Ochocki S., O'Neill W., and Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 328 (1993) 673-679
19. De Luca G., van't Hof A.W., de Boer M.J., Ottervanger J.P., Hoorntje J.C., Gosselink A.T., Dambrink J.H., Zijlstra F., and Suryapranata H. Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty. Eur Heart J 25 (2004) 1009-1013
20. Zhu M.M., Feit A., Chadow H., Alam M., Kwan T., and Clark L.T. Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction: a meta-analysis of randomized clinical trials. Am J Cardiol 88 (2001) 297-301
21. Vlaar P.J., Svilaas T., Damman K., de Smet B.J., Tijssen J.G., Hillege H.L., and Zijlstra F. Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review. Circulation 118 (2008) 1828-1836
22. Montalescot G., Barragan P., Wittenberg O., Ecollan P., Elhadad S., Villain P., Boulenc J.M., Morice M.C., Maillard L., Pansiéri M., Choussat R., Pinton P., and ADMIRAL Investigators. Abciximab before direct angioplasty and stenting in myocardial infarction regarding acute and long-term follow-up: platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 344 (2001) 1895-1903
23. Somitsu Y., Nakamura M., Degawa T., and Yamaguchi T. Prognostic value of slow resolution of ST-segment elevation following successful direct percutaneous transluminal coronary angioplasty for recovery of left ventricular function. Am J Cardiol 80 (1997) 406-410
24. Santoro G.M., Antoniucci D., Valenti R., Bolognese L., Buonamici P., Trapani M., Boddi V., and Fazzini P.F. Rapid reduction of ST-segment elevation after successful direct angioplasty in acute myocardial infarction. Am J Cardiol 80 (1997) 685-689
25. Claeys M.J., Bosmans J., Veenstra L., Jorens P., De Raedt H., and Vrints C.J. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation 99 (1999) 1972-1977
26. Matetzky S., Novikov M., Gruberg L., Freimark D., Feinberg M., Elian D., Novikov I., Di Segni E., Agranat O., Har-Zahav Y., Rabinowitz B., Kaplinsky E., and Hod H. The significance of persistent ST elevation versus early resolution of ST-segment elevation after primary PTCA. J Am Coll Cardiol 34 (1999) 1932-1938
27. Chesebro J., Knatterud G., Roberts R., Borer J., Cohen L.S., Dalen J., Dodge H.T., Francis C.K., Hillis D., Ludbrook P., Markis J.E., Mueller H., Passamani E.R., Powers E., Rao A.K., Robertson T., Ross A., Ryan T.J., Sobel B.E., Willerson J., Williams D., Zaret B., and Braunwald E. Thrombolysis In Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge. Circulation 76 (1987) 142-154
28. Terkelsen C.J., Nørgaard B.L., Lassen J.F., Poulsen S.H., Gerdes J.C., Sloth E., Gøtzsche L.B., Rømer F.K., Thuesen L., Nielsen T.T., and Andersen H.R. Potential significance of spontaneous and interventional ST-changes in patients transferred for primary percutaneous coronary intervention: observations from the ST-MONitoring in Acute Myocardial Infarction study (the MONAMI study). Eur Heart J 27 (2006) 267-275
29. Rakowski T., Dziewierz A., Siudak Z., Mielecki W., Brzozowska-Czarnek A., Legutko J., Rzeszutko L., Urbanik A., Dubiel J.S., and Dudek D. ST-segment resolution assessed immediately after primary percutaneous coronary intervention correlates with infarct size and left ventricular function in cardiac magnetic resonance at 1-year follow-up. J Electrocardiol 42 (2009) 152-156
30. Antman E.M., Cooper H.A., Gibson C.M., de Lemos J.A., McCabe C.H., Giugliano R.P., Coussement P., Murphy S., Scherer J., Anderson K., Van de Werf F., Braunwald E., and Thrombolysis In Myocardial Infarction (TIMI) 14 Investigators. Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II. Eur Heart J 23 (2002) 928-933